| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 2od | Human G9a in Complex with Inhibitor A-366 | 4nvq | 91.94 |
| 2 | 7kz | Crystal structure of catalytic domain of G9a with MS012 | 5ttf | 81.04 |
| 3 | 7l6 | Structure of human G9a SET-domain (EHMT2) in complex with inhibitor MS0124 | 5tuy | 77.92 |
| 4 | 9hg | Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 17: N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine | 5vse | 77.92 |
| 5 | 9hj | Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 13 | 5vsc | 76.94 |
| 6 | 90p | Crystal structure of catalytic domain of G9a with MS0105 | 5v9i | 76.91 |
| 7 | dxq | Discovery of a 2,4-Diamino-7-aminoalkoxy-quinazoline as a Potent Inhibitor of Histone Lysine Methyltransferase, G9a | 3k5k | 76.16 |
| 8 | ciq | Crystal structure of histone lysine methyltransferase g9a with an inhibitor | 3rjw | 70.11 |